[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100293799":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":89,"collaborators":18,"id":93,"slug":94,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":18,"eligibilityCriteria":99,"healthyVolunteers":95,"sex":100,"minAge":101,"maxAge":102,"enrollmentInfo":103,"targetDuration":18,"studyType":106,"phases":107,"briefSummary":109,"conditions":110,"keywords":112,"overallStatus":117,"whyStopped":18,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"Hepatopancreatobiliary Surgery Institute of Gansu Province","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Injection of 37℃ contrast agent","EXPERIMENTAL","Nonionic contrast agent is heated to 37℃ during ERCP when injection of contrast agent",[13],"Procedure: Injection of 37℃ contrast agent",{"label":15,"type":16,"description":17,"interventionNames":18},"Injection of normal contrast agent","NO_INTERVENTION","Normal temperature nonionic contrast agent can be used in ERCP when injection of contrast agent",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"PROCEDURE","Nonionic contrast agent is heated to 37℃ in a incubator when injection of contrast agent",[9],[25],{"name":26,"affiliation":5,"role":27},"Xun Li, M.D., Ph. D.","STUDY_CHAIR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Wenbo Meng, M.D., Ph. D.","CONTACT","+8613919177177","mengwb@lzu.edu.cn",{"name":26,"role":31,"phone":35,"phoneExt":18,"email":36},"+8613993138612","drlixun@163.com",[38,59,74],{"facility":39,"status":18,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"The first hospital of Lanzhou university","Lanzhou","Gansu","730000","China","CN",{"type":46,"coordinates":47},"Point",[48,49],103.83987,36.05701,{"lat":49,"lon":48},[52,56],{"name":53,"role":31,"phone":54,"phoneExt":18,"email":55},"Wence Zhou, M. D.","+8609318356919","zhouwc129@163.com",{"name":57,"role":31,"phone":58,"phoneExt":18,"email":33},"Wenbo Meng, M. D.","+8609318356213",{"facility":60,"status":18,"city":61,"state":62,"zip":63,"country":43,"countryCode":44,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"The first affiliated hospital of Xi 'an jiaotong university","Xi'an","Shaanxi","710061",{"type":46,"coordinates":65},[66,67],108.92861,34.25833,{"lat":67,"lon":66},[70],{"name":71,"role":31,"phone":72,"phoneExt":18,"email":73},"Hao Sun, M. D.","+86 13891813691","sunhaoxjfy@126.com",{"facility":75,"status":18,"city":76,"state":77,"zip":78,"country":43,"countryCode":44,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Tianjin Nankai Hospital","Tianjin","Tianjin Municipality","300100",{"type":46,"coordinates":80},[81,82],117.17667,39.14222,{"lat":82,"lon":81},[85],{"name":86,"role":31,"phone":87,"phoneExt":18,"email":88},"Zhenyu Wang, M. D.","+86 15302021661","Wangzytj@163.com",{"type":90,"investigatorFullName":91,"investigatorTitle":92,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Xun Li","M.D., Ph. D, Director.","100293799","effect-of-37-non-ionic-contrast-agent-during-ercp-procedure-in-hilar-cholangiocarcinoma-100293799",false,"NCT03104569","Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma","Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma: A Prospective Double-blind Multicenter Randomized Controlled Study","Inclusion Criteria:\n\n* Type Ⅰ、Ⅱ、Ⅲ、Ⅳ of Hilar Cholangiocarcinoma;\n* Age: 18\\~90 years old;\n* Underwent diagnostic and therapeutic ERCP;\n\nExclusion Criteria:\n\n* Coagulation dysfunction(INR\\>1.3) or\u002Fand low peripheral blood platelet count （PLT \\\u003C50x10\\^9\u002FL）;\n* Preoperative acute cholangitis;\n* Preoperative acute pancreatitis;\n* Preoperative hemobilia or hemorrhage of digestive tract;\n* Preoperative liver failure;\n* Combined with Mirizzi syndrome and intrahepatic bile duct stones;\n* Preoperative malignant tumor of biliary system such as carcinoma of head of pancreas, gallbladder carcinoma;\n* Biliary-duodenal fistula confirmed during ERCP;\n* A history of reconstructive surgery for upper digestive tract except Billroth Ⅰand a history of cholangioenterostomy including cholangio-jejunostomy and side to side anastomosis of the bile duct and duodenum;\n* Previous ERCP;\n* Pregnant women","ALL","18 Years","90 Years",{"count":104,"type":105},100,"ESTIMATED","INTERVENTIONAL",[108],"NA","The purpose of this study is to determine the effect of normal temperature and 37℃ non-ionic contrast agent acting on ERCP-related cholangeitis after endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of hilar cholangiocarcinoma.",[111],"Cholangitis",[113,114,115,111,116],"ERCP","Contrast agent","Hilar cholangiocarcinoma","Nonionic","NOT_YET_RECRUITING","2025-12-19",{"date":120,"type":121},"2025-12-26","ACTUAL",{"date":123,"type":105},"2026-04-01",{"date":125,"type":105},"2028-12-01",{"name":5,"class":6},3]